Gene Promoter Hypermethylation in Tumors and Plasma of Breast Cancer Patients
Authors:
Open Access
- 1 January 2005
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 37 (4) , 233-240
Abstract
Bae YK, et al. Cancer Res Treat. 2005 Aug;37(4):233-240. http://dx.doi.org/10.4143/crt.2005.37.4.233Keywords
This publication has 26 references indexed in Scilit:
- In vitro Induction of Myeloid Leukemia–Specific CD4 and CD8 T Cells by CD40 Ligand – Activated B Cells Gene Modified to Express Primary Granule ProteinsClinical Cancer Research, 2005
- Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer PatientsClinical Cancer Research, 2004
- Hypermethylation in Histologically Distinct Classes of Breast CancerClinical Cancer Research, 2004
- Circulating Nucleic Acids and Proteomics of Plasma/Serum: Clinical UtilityAnnals of the New York Academy of Sciences, 2004
- 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 HospitalsCancer Research and Treatment, 2004
- DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinomaInternational Journal of Cancer, 2003
- TP53and breast cancerHuman Mutation, 2003
- HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cellsProceedings of the National Academy of Sciences, 2001
- Microsatellite alterations in plasma DNA of small cell lung cancer patientsNature Medicine, 1996
- Microsatellite alterations in serum DNA of head and neck cancer patientsNature Medicine, 1996